Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-000899
Filing Date
2025-02-14
Accepted
2025-02-14 09:01:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10308
  Complete submission text file 0001172661-25-000899.txt   12160
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88022 | Film No.: 25623718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1120 AVENUE OF THE AMERICAS SUITE 1502 NEW YORK NY 10036
Business Address 1120 AVENUE OF THE AMERICAS SUITE 1502 NEW YORK NY 10036 3475146126
Union Square Park Capital Management, LLC (Filed by) CIK: 0001666231 (see all company filings)

EIN.: 472757696 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A